Placebo effects during the waiting period for psychotherapy in patients with depression

Placebo effects during the waiting period for psychotherapy in patients with depression - Waiting-list psychotherapy and depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028118

Enrollment

Registered

2022-08-09

Start date

2022-03-14

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression F32

Interventions

Group 1: placebo

daily over three weeks Group 2: no placebo

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: primary diagnosis depression

Exclusion criteria

Exclusion criteria: psychotic symptoms; substance abuse; acute suicidality

Design outcomes

Primary

Measure	Time frame
Scores on the Beck Depression Inventory (BDI-II) before and after three weeks of waiting for psychotherapy	—

Secondary

Measure	Time frame
Likert scales (1-10) to evaluate one's energy level, sleep quality, concentration, well-being, relaxation (1 time/ per week)	—

Countries

Austria

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.az03163805086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026